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Background: Retroperitoneal tumors (RTs) develop insidiously and are generally seen as large masses, and 50% of
RTs are larger than 20 cm at the time of diagnosis. In this article, we share our experience of 5 years of surgical
management of RTs.
Methods: We evaluated 28 RT cases operated on in three education hospitals in Turkey from January 2008
onwards, with regard to patients’ demographic characteristics, complaints, weight loss figures, the location and size
of the tumor, blood transfusion, intra-operational time, metastases (in malignant cases), additional organ resection,
histological grade, local recurrences, average life expectancy, and post-operative treatment methods.
Results: The mean age of the patients was 49 years (range, 18 to 78 years). Twenty (71.43%) were female, and
8 (28.57%) were male. The primary complaint was abdominal pain in 18 patients (64.28%). CT scans were performed
in 17 (61%) patients, 10 (35.4%) underwent abdominal MR imaging, and 1 (3.6%) underwent both abdominal CT
and abdominal MR imaging. A mass was palpated in the pelvis (suprapubic region) in seven (25%) of the patients
during physical examination. The largest tumors were detected in the left lumbar area. The mean tumor size was
12.78 cm (range, 2 to 30 cm). The mean intra-operational time was 192 min (range, 70 to 380 min). The mean
hospitalization period was 11 days (range, 8 to 23 days). Seven (25%) patients were reported to have benign tumors,
while 21 (75%) were reported to have malignant tumors. The most frequently seen malignant pathology was
liposarcoma (eight cases; 38.09%) followed by leiomyosarcoma (five cases; 23.8%) and malignant fibrous histiocytoma
(four cases; 19.04%). The earliest local recurrence was detected in the 12th month and the latest in the 28th month. A
total of 11 (52.3%) of the total of 21 malignant cases experienced local recurrence within 3 years. The 3-year average life
expectancy was 85.7% in the 18 malignant cases.
Conclusions: Due to the low response rate of all but two types of RT to chemotherapy, the best remaining treatment
option is surgery with wide resection margins, whereby all macroscopic traces of tumor are removed.
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Retroperitoneal tumors (RTs) commonly present with
abdominal distention and palpable mass. In many cases,
they are detected as a result of imaging techniques per-
formed to investigate unrelated issues. Although RTs can
be located in the gastrointestinal and urinary tracts, pa-
tients rarely present with symptoms in these systems
[1,2]. The retroperitoneal space is the second most* Correspondence: drkazimgemici@hotmail.com
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unless otherwise stated.frequent location, followed by the lower extremities,
where malignant mesenchymal tumors arise. Each year,
approximately 250 to 300 new cases of retroperitoneal
sarcoma are diagnosed in the United Kingdom [3]. Des-
pite the rare nature of RTs, two thirds of these diagnoses
represent malignant tumors. Approximately, one third
of RT cases are sarcomas. The most frequent sarcomas
are liposarcoma, malignant fibrous histiocytoma, and
leiomyosarcoma, respectively. Other malignant RT types
are lymphoma, epithelial tumors, malignant paragan-
glioma (which is considered to be benign when no me-
tastasis occurs), and metastatic tumors. Fibromatosis,This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/4.0), which permits unrestricted use, distribution, and
iginal work is properly credited. The Creative Commons Public Domain
g/publicdomain/zero/1.0/) applies to the data made available in this article,
Figure 1 CT image of lipoma in the lower left quadrant.
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fibroma, lipoma, angiofibroma, and schwannoma can be
listed among the benign tumors. The majority of sarco-
mas in the RT region cannot be completely removed
surgically because of their close proximity to vital organs
(in contrast to tumors located in the extremities). Des-
pite this, surgery remains the most successful treatment
method for RTs, significantly affecting post-operative
survival [4]. RTs develop insidiously and are generally
seen as large masses; 50% of RT is larger than 20 cm at
the time of diagnosis. RTs develop without suppressing
the inner organs or causing significant lumen blockage
and are frequently confused with lymphomas. Full phys-
ical examination, evaluation of all peripheral lymph
nodes, and testis examination for male patients are im-
portant when approaching patients with RT. RT liposar-
comas are most frequently seen between 50 and 70
years of age. With a 5-year survival rate of between 40%
and 50% [5], the prognosis is worse than that of other
soft tissue sarcomas regarding local recurrence. The goal
in surgical management of RTs is to achieve the optimal
negative surgical border. In the presence of a positive
surgical border, the 5-year survival rate decreases to
28%. Delayed diagnosis, high histological grade, inoper-
ability due to invasion into vital organs, and a positive
surgical border can be listed among the most significant
factors affecting survival. The average life expectancy for
patients with high-grade RTs is 20 months, while for
low-grade RTs, it is 80 months; moreover, RTs largerTable 1 Characteristics of the patients and tumors
Characteristics Value
Age (n = 28)
Male 38 (18 to 54)




Grade (n = 21)
Grade 1 10 (47.61%)
Grade 2 7 (33.33%)
Grade 3 4 (19.06%)
Tumor size (n = 28)
≤10 cm 13 (46.42%)
11 to 20 cm 11 (39.28%)




Weightlossa 4.3 (±1.2) kg
aIn the last 6 months.than 10 cm generally had distant metastasis at the time
of diagnosis [6].
Methods
Twenty-eight patients diagnosed with RT were operated
on at three distinct education hospitals in Turkey between
2008 and 2013. Written informed consent was obtained
from each individual before surgical procedure. Patients
were followed-up for 3 years. The patients’ clinical re-
cords, radiology reports, and pathology reports were eval-
uated, and their demographic characteristics, complaints,
amount of weight loss, the location and size of tumors asFigure 2 Appearance of lipoma (15 cm).
Table 2 Histopathological distribution of RTs
Tissue type Number (%)
Malignant (n = 21)
Lyposarcoma 8 (38.09%)
Leiomyosarcoma 5 (23.80%)
Malign fibrous histiocytoma 5 (23.80%)
Malign paraganglioma 1 (4.76%)
Hodgkins lymphoma 1 (4.76%)
Fibrosarcoma 1 (4.76%)






Benign paraganglioma 1 (14.28%)
Figure 4 Post-operative sight of a malign paraganglioma (17 cm).
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suprapubic (SP), left lower quadrant (LLQ), and left upper
quadrant (LUQ) were determined. In addition, incidences
of blood transfusion, operation time, metastases if de-
tected, additional organ resections, histological grades,
local recurrences, hospitalization periods, average life ex-
pectancy, and post-operative treatments of the patients
were analyzed. Wide resection (WR) with safe margins was
performed in patients with a single tumor while WR cover-
ing both the main tumor and any nodules was performed
in patients with nodular spread in addition to the main
tumor. Wound infection, wound separation, hemorrhage,
pneumonia, re-operation, sepsis, intra-abdominal abscess,
ileus, deep vein thrombosis, and enterocutaneous fistulaFigure 3 Pre-operative CT image of malign paraganglioma.were observed to be the most important post-operative
complications. RT sizes were determined by taking the
maximum diameters into consideration. The patients were
called in for follow-up every 3 months in the first year
and every 6 months in the second and third years, in the
absence of complaints. Abdominal CT or MR imaging
was performed during the 6-month follow-up analyses.
Results
Table 1 presents patients’ demographic characteristics,
tumor grades, tumor sizes, additional organ resections,
and features of wezight loss. The mean hospitalization
period was 11 days (ranging from 8 to 23 days). WhileFigure 5 CT image of paraganglioma at the sixth months.
Table 3 The localizations of the tumors and the sizes of the malignant tumors according to metastasis status
Region n (%) Mean tumor size (cm) Metastasis status Number = 21 (%) Size (cm) mean
RUQ 1 (3.57%) 2 Nodular 5 (23.80%) 14.2
RIQ 2 (7.14%) 10 Liver + Nodular 1 (4.76%) 16
LUQ 6 (21.42%) 13.3 Right tubo-ovarian 1 (4.76%) 6
LIQ 6 (21.42%) 8.8 + Nodular
LLR 3 (10.71%) 23.3 Left kidney + Nodular 1 (4.76%) 30
SNT 3 (10.71%) 17.3 Spleen, stomach 1 (4.76%) 17
SP 7 (25%) 11.5 Aortic 1 (4.76%) 24
Aortic, VCI 1 (4.76%) 10
Colon 1 (4.76%) 8
Spleen 1 (4.76%) 15
None 8 (38.1%) 10.5
RUQ: Right upper quadrant, RIQ: Right inferior quadrant, LUQ: Left upper quadrant, LIQ: Left inferior quadrant, LLR: Left lumbar region, SNT: Periumblical region,
SP: Suprapupic region, VCI: Vena cava inferior.
Figure 6 CT image of left kidney being pushed laterally and
anteriorly to the right.
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male. The mean age-age ranges for female and male pa-
tients were 55 (28 to 78) and 38 (18 to 54) years, re-
spectively. Average weight loss in the last 6 months was
4.3 (±1.2) kg. The primary complaints of the patients
were abdominal pain in 18 patients (64.28%), abdominal
induration in 9 (32.14%), and loss of strength in the right
foot in 1 (3.58%) patient. The beginning of the com-
plaints could be traced back an average of 8 months.
Twenty-one (75%) of the RTs were malignant, while 7
(25%) were benign (Figures 1 and 2), and the most fre-
quent pathologies were liposarcoma in 8 (38.1%) pa-
tients, leiomyosarcoma in 5 (23.8%), malignant fibrous
histiocytoma in 5 (23.8%), and malignant paraganglioma
in 1 (4.76%) patient who had generalized intra-abdominal
metastasis in the sixth month (Table 2). The same patient
was lost in the second year (Figures 3, 4 and 5).
In three (10.7%) cases, wound infection was experi-
enced; these patients recovered in an average of 6 days
through local drainage and appropriate antibiotic treat-
ment based on culture antibiogram. Two (7.1%) patients
suffered from ileus, recovering within 3 to 7 days follow-
ing nasogastric decompression and medical treatment.
One (3.5%) obese patient had the complication of pneu-
monia, which was confirmed radiologically and through
culture; this patient’s clinical and radiological symptoms
regressed after 15 days of antibiotic treatment.
CT scans were performed in 17 (61%) patients, 10
(35.4%) had abdominal MR imaging, and 1 (3.6%) had
both abdominal CT and abdominal MR imaging. A mass
was palpated in the pelvis (suprapubic region) of seven
(25%) patients during physical examination, with the
second most frequent area of mass palpation in the left
upper quadrant in six (21.4%) patients. The least fre-
quent area of observation of a mass was the right upper
quadrant, in one (3.57%) patient.The largest tumors were detected in the left lumbar
area. The smallest tumor was in the right upper quadrant.
The average tumor size in malignant cases with no macro-
scopic metastases was 10.5 cm, and the most frequent
spread was in nodular form besides the main tumor in
eight (38.1%) patients in the malignant group (n = 21)
(Table 3). Patients who had isolated tumors with no nodu-
lar spread underwent wide resection. Those with nodular
spread had wide resection both to the main tumor and
the nodules. Wide resection and splenectomy were per-
formed in one patient with spleen metastasis. One (4.76%)
patient, in whom spleen and stomach invasion was de-
tected, underwent wide resection plus splenectomy and
stomach wedge resection. The location of intra-abdominal
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of the mass, with the kidneys being the most common
viscera with an altered intra-abdominal location. In our
series, one RT (longest length measuring 30 cm)
pushed the left kidney to the right anterolateral direc-
tion (Figure 6). Since the left kidney was completely
engulfed by the mass and many nodular tumor implants
were detected during imaging work-up, the patient under-
went multiple WR (MWR) and a left nephrectomy. An in-
cision biopsy procedure was performed in one distinct
patient with aortic invasion, and the result was reported
to be grade 3 liposarcoma. Biopsy was performed in one
patient with aorta and vena cava inferior invasion and the
result was Hodgkin’s lymphoma (mixed type). Wide resec-
tion and left hemicolectomy were performed in oneTable 4 Characteristics of all surgical procedures
Patient Tumor size (cm) Operation Histo
1 12 WTR LS
2 20 WTR LMS
3 6 MWTR + RSO FS
4 8 WTR NF
5 17 WTR L
6 30 MWTR LS
7 8 WTR FR
8 12 WTR LS
9 16 WTR LMS
10 19 MWTR LMS
11 30 MWTR + LN LS
12 15 WTR + SP PRG
13 25 WTR ANGF
14 6 MWTR LMS
15 11 MWTR MFH
16 7 WTR SWN
17 8 WTR NF
18 5 MWTR MFH
19 3 WTR LS
20 16 MWTRa LS
21 4 WTR LMS
22 17 WTR + SP + WRS MFH
23 15 WTR LS
24 24 BPYb LS
25 2 WTR MFH
26 8 WTR + LHC MFH
27 4 WTR PRG
28 10 BPYc HL
LS: Liposarcoma, LMS: Leiomyosarcoma, MFH: Malignant fibrous histiocytoma, FS: F
ANGF: Angiofibroma, SWN: Schwannoma, HL: Hodgkin’s Lymphoma , WTR: Wide tot
nodular progression), RSO: Right salpingo-oophorectomy, LN: Left Nephrectomy, SP: Sp
BPY: Biopsy, FFP: Fresh frozen plasma. aLiver metastases; baortic invasion; caortic and vpatient with left colon invasion (Table 4). The earliest local
recurrence was detected in the 12th month and the latest
in the 28th month. A total of 11 (52.3%) of a total of 21
malignant cases experienced local recurrence within 3
years. The 3-year average life expectancy was 85.7% in 18
patients among the malignant cases. Three (14.3%) pa-
tients died due to widespread intra-abdominal recurrence
and hepatic metastasis, while one patient was lost because
of lung metastasis in addition to generalized metastasis.
Ten (47.61%) patients with satellite nodules and visceral
involvement received post-operative radiotherapy. Five
(23.8%) patients received chemotherapy (CT) in addition
to radiotherapy (RT).
The mean operation time was 192 min (ranging from
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ibrosarcoma, PRG: Paraganglioma, L: Lipoma, NF: Neurofibroma, FR: Fibroma,
al resection, MWTR: Multiple wide total resection (applied for the patients with
lenectomy, LHC: Left hemicolectomy, WRS: Wedge resection of the stomach,
ena cava invasion.
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massive hemorrhage during the operation. The average
amount of blood needed was 1.5 U in our series. A pa-
tient whose pathology was reported to be grade 3 lipo-
sarcoma, which is presented as the sixth item in Table 4,
received wide resection with safe margins including sat-
ellite nodules, removing all macroscopic tumor traces
during the procedure; the patient also received post-
operative CT plus RT (Figure 7). When the patient pre-
sented to their third follow-up in the 12th month,
abdominal ultrasonography (USG) revealed multiple wide-
spread nodular implants, the largest of which was 16 cm,
and widespread liver and lung metastases. This patient
was lost in the 15th month. The patient with colon inva-
sion was also lost in the 25th month due to widespread
abdominal and hepatic metastasis.
Discussion
RTs are challenging for surgeons due to their inaccessible
location, unpredictable clinical behavior, and lack of suc-
cessful treatments. A diagnosis can be reached through
the evaluation of complaints, clinical findings, imaging
methods, and Trucut biopsy. The most common tumors
among the malignant group are liposarcomas. These tu-
mors generally tend to be of low and intermediate grades.
In it has been reported that the following are negative
prognostic factors: poorly differentiated type, grade 2 to 3
tumor, stage 2 to 3 tumor, tumor size larger than 20 cm,
and a positive surgical border [7]. The well-known grad-
ing systems for sarcomas currently in use at present are
those of the National Cancer Institute (NCI) and French
Federation of Cancer Centers (FFCLCC) [8]. Within the
framework of a study evaluating 500 patients with retro-
peritoneal sarcoma, who were treated at the MemorialFigure 7 CT image of grade 3 liposarcoma in size of 30 cm
(pleomorphic type).Sloan-Kettering Cancer Center, it was found that while
the average life expectancy for patients who had com-
plete resection was 103 months, this decreased to 18
months for patients who had incomplete resection or
whose tumors were inoperable [9]. While studies have
found that the 5-year average life expectancy for well-
differentiated liposarcoma was 90%, this percentage
decreases to 30% to 50% for pleomorphic type liposarco-
mas. Liposarcomas of low grade have a high tendency to
locally recur, but their tendency to distantly metastasize
is low. Pleomorphic liposarcomas, however, tend to have
a high tendency to distantly metastasize, and this feature
has been held responsible for the decrease in average life
expectancy. In our series, the earliest death happened in
the 15th month in a patient with grade 3 liposarcoma of
pleomorphic histological type. Since poorly differentiated
liposarcomas tend to invade intra-abdominal organs
more frequently, additional organ resections are often
needed in these cases [10]. In 2000, Linehan et al. studied
159 patients diagnosed with RTs and found that the in-
crease in tumor size played a significant role in the in-
crease of local recurrence and in metastasis rates [11].
The largest tumor size in our series was 30 cm. In pa-
tients with large tumors, if the existence of RTs is con-
firmed through imaging, pre-operative biopsy would not
be recommended due to the risk of tumor spread during
the biopsy procedure. The majority of patients with RTs
have local recurrences, and 75% of sarcoma-related deaths
are based on these recurrences. This should be taken into
consideration in all RT cases, with the exception of soft
tissue sarcomas. For instance, intra-abdominal sarcomas
can be frequently confused with retroperitoneal sarcomas
and if imaging results cause practitioners to suspect
lymphoma, core needle biopsy should be performed [12].
Since RTs frequently invade vital organs, complete macro-
scopic clearing can only be achieved in 55% to 93% of the
patients. In our series, additional organ resection was
needed in five patients. Splenectomy was performed in
one patient because of spleen invasion, splenectomy and
stomach wedge resection were performed in another pa-
tient because of spleen and stomach invasion, while left
hemicolectomy was performed in one patient because of
left colon invasion. One patient received left nephrec-
tomy since the left kidney had completely surrounded
the mass (Figure 6), and in another patient, right
salpingo-oophorectomy was indispensable because the
mass invaded the right ovary and fallopian tube. Palliative
surgery is recommended for patients diagnosed with low
and intermediate grade RTs in the case of local recur-
rence to manage the symptoms and to increase the pa-
tients’ quality of life [13]. Studies conducted at Johns
Hopkins University School of Medicine in 2009 with
1,365 cases and at Anderson Cancer Center in Houston
in 2008 with 1,091 cases showed that the biology of
Gemici et al. World Journal of Surgical Oncology  (2015) 13:143 Page 7 of 8tumors and complete surgical resection were the keys to
treatment [14]. Liposarcomas are generally rooted in
perinephric fat tissues and, as they grow, cause shifting of
the kidneys’ original location. This was clearly seen in
our series in Figure 6, and colon resection alongside the
kidney is performed frequently in such cases [15]. There
is no strong evidence for the utility of radiotherapy or
chemotherapy for treatment of RTs [16]. Since there is
no prospective randomized controlled study on the ef-
fectiveness of radiotherapy, most of the data are based on
retrospective studies [17]. The dose and duration of
radiotherapy are limited because of its toxic effect on the
gastrointestinal tract. Pre-operative, intra-operative, and
post-operative radiotherapy can be effective, but only in a
small proportion of patients [18-21]. Radiotherapy is espe-
cially recommended for patients with high-grade tumors
and those for whom complete resection is impossible
[22,23]. In RT surgical procedures, the organs, which are
frequently resected, in addition to the primary tumor, are
the kidneys, colon, pancreas, and spleen [24]. In some tu-
mors, such as the Ewing tumors, chemotherapy forms a
significant part of the treatment, while for some particular
histological types, special chemotherapeutic agents are
sometimes used. These include agents such as doxorubi-
cin and ifosfamide for the palliation of sarcomas, taxanes
for angiosarcomas, gemcitabine and docetaxel for leio-
myosarcomas, and trabectedin for mixoid-round cell lipo-
sarcomas and leiomyosarcomas [25]. Leiomyosarcoma
and malignant fibrous histiocytoma have worse prognoses
in comparison to liposarcoma. The extent of distant me-
tastases is worse than for their local recurrences [26,27].
In cases which are histopathologically confirmed to be be-
nign, for instance in schwannomas, surgery is performed
if the patient is symptomatic; on the other hand, if there
are no symptoms, the patient can be followed up through
imaging following tissue diagnosis [28]. The genetic and
molecular complexity of tumors needs to be elucidated to
gain a better understanding of the biological behavior of
these tumors and to offer better treatment options [29,30].
Conclusions
In this study, we analyzed 28 patients diagnosed with
retroperitoneal tumors, based on data retrieved from
three distinct training and education hospitals in Turkey.
The results we found were similar to those published in
the literature. It is recommended that retroperitoneal tu-
mors are immediately treated by an experienced team of
surgeons, employing a multidisciplinary approach. The
only current treatment option that is known to prolong
survival in patients with these tumors is wide surgical
resection. While the efficiency of pre-operative and post-
operative radiotherapy and chemotherapy is still a con-
troversial issue, wide surgical resection for treatment of
RTs remains the gold standard procedure.Abbreviations
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